By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
February 8, 2026 7:37 PM EST
Medical Herald
Search
  • Health Conditions
    Health ConditionsShow More
    Understanding the Key Difference Between PCOD vs PCOS: What Every Woman Should Know
    Understanding the Key Difference Between PCOD vs PCOS: What Every Woman Should Know
    Health Conditions
    Diet Drinks Linked to Increased Liver Disease Risk, Study Finds
    Health Conditions
    Experts Urge Rethink on Prediabetes Diagnosis and Treatment
    Diabetes
    Study Highlights Rising Heart Risks in Pregnant Women
    Pregnancy & Parenting
    ‘New Mom School’ Helps Women Through Postpartum Challenges
    Pregnancy & Parenting
  • Wellness & Self-Care
    Wellness & Self-CareShow More
    Herbal Foot Baths: Ancient Practice Gains Modern Wellness Traction
    Wellness & Self-Care
    Boosting Immunity: The Power of Holistic Approaches
    Healthy Living
    Understanding Major Causes of Death in America
    Healthy Living
    Study Links Chatbot Use to Increased Symptoms of Depression
    Mental Health
    Transforming Anxiety and Stress into Joy and Fulfillment
    Wellness & Self-Care
  • Nutrition & Fitness
    Nutrition & FitnessShow More
    Shilajit Benefits
    Shilajit Benefits: Ancient Himalayan Secret for Energy, Brain Health, and Longevity
    Nutrients & Supplements
    Affordable Grain-Based Dishes for a Healthier Diet
    Healthy Recipes
    Understanding Prebiotics and Probiotics for Better Health
    Nutrition & Fitness
    Minnesota Health Officials Warn of Salmonella in Supplements
    Nutrients & Supplements
    Fibermaxxing: The Rising Trend in Nutritional Focus
    Diet & Nutrition
  • Innovation
    InnovationShow More
    Weight-Loss Drugs Require Lifelong Use, New Study Indicates
    Drugs & Medications
    Structure Therapeutics Faces Challenges with Weight-Loss Treatments
    Drugs & Medications
    Dr. Hosen Kiat: Advancing the Frontiers of Cardiovascular Science
    Innovation
    FDA Issues Warning for J&J and Legend’s Cancer Treatment Carvykti
    Drugs & Medications
    GLP-1 Medications Transform Health and Household Budgets
    Drugs & Medications
  • News
    NewsShow More
    Challenging the 1918 Influenza Pandemic Narrative on BrightU
    News
    Brazilian Fitness Influencer in Coma After Diving Accident
    News
    Chelsea Handler Declares Love for Drugs and Dismisses Sober Dating
    News
    New Leadership at Parenting Resource Center in Austin
    News
    Advances in Nigeria’s Real-Time NTD Treatment Reporting System
    News
Font ResizerAa
Medical HeraldMedical Herald
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Search
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Follow US
Copyright © 2025, Medical Herald. All Rights Reserved.
Home » Innovation » How ALV-J Virus Bypasses Immune Defense Using miR-155

How ALV-J Virus Bypasses Immune Defense Using miR-155

Samuel Lee
By Samuel Lee
Published: October 27, 2025
5 Min Read
Share

Avian leukosis virus subgroup J (ALV-J) is a significant oncogenic retrovirus that leads to severe health issues in poultry, including immunosuppression and the formation of tumors like myelocytomas. While previous research has established that ALV-J can evade innate immunity, the specific mechanisms behind this evasion have remained elusive. Recent studies reveal that ALV-J enhances the expression of microRNA-155 (miR-155), a key player in the suppression of immune responses, ultimately facilitating viral replication.

In our research, we identified that the p27 viral protein from ALV-J significantly reduces the activity of a cellular protein called DEAD-box helicase 3X (DDX3X). This action diminishes DDX3X expression and promotes the maturation of the MIR155 host gene into active miR-155. The mature miR-155 then targets two crucial proteins, tumor necrosis factor receptor-associated factor 3 (TRAF3) and signal transducer and activator of transcription 1 (STAT1), both of which are essential for the initiation of type I interferon (IFN-I) responses. By silencing TRAF3 or STAT1, researchers found that ALV-J replication, which would normally be inhibited by miR-155, is restored.

This discovery marks a notable advance in understanding the immune evasion tactics employed by retroviruses such as ALV-J, shedding light on their complex pathogenesis.

Author Summary

ALV-J is known for causing considerable economic repercussions in the poultry industry due to its ability to disrupt immune function and induce tumors. Our study illuminates how ALV-J manipulates the host microRNA, miR-155, to escape the body’s antiviral responses. By compromising the function of DDX3X, ALV-J can increase miR-155 levels. This rise in miR-155, in turn, blocks the action of TRAF3 and STAT1—critical regulators in the immune response—thereby suppressing the production of interferons that would typically hinder viral replication. Through this mechanism, the virus effectively lowers its chances of being eradicated by the host immune system.

Introduction

ALV-J represents a rapidly evolving oncogenic retrovirus that poses significant health threats to poultry by inducing immunosuppression and neoplastic diseases. These conditions lead to reduced growth rates, susceptibility to infections, and overall productivity losses in affected flocks. The virus can spread both horizontally and vertically, with vertical transmission linked to more pronounced pathogenic effects, especially during early stages of a chicken’s life.

The ability of ALV-J to evade the host immune response is crucial for its infection and persistence. This evasion is facilitated by the virus’s unique strategies that exploit host factors, such as miRNAs, to counteract antiviral defenses. However, the underlying mechanisms by which ALV-J escapes immune detection remain less well-defined.

miRNA and Immune Evasion

miRNAs are small, non-coding RNAs that regulate gene expression. They play significant roles in both innate and adaptive immune responses, making them intriguing targets for viral immune evasion strategies. For instance, studies have shown that several oncogenic viruses effectively manipulate host miRNA functions to promote their own longevity and pathogenicity.

Our research highlights that while ALV-J induces various miRNAs, including miR-200b-3p, miR-34b-5p, and miR-23b, miR-155 is particularly prominent in the virus’s ability to escape immune responses. Elevated levels of miR-155 were found to block critical components of the host’s antiviral response, particularly affecting IFN production.

Experimental Findings

To explore how ALV-J influences miR-155 levels and subsequent immune suppression, CEFs (chicken embryo fibroblasts) were infected with ALV-J, revealing that infection led to a substantial increase in miR-155 levels. Notably, DDX3X was identified as a significant interacting partner that p27 protein of ALV-J targets to promote miR-155 maturation.

Following this, functional assays demonstrated that increasing miR-155 exerted a negative impact on ALV-J-induced IFN-β production, highlighting the intricate mechanism by which ALV-J manipulates the host immune response. Importantly, DDX3X overexpression was found to reverse the miR-155 induced decrease in TRAF3 and STAT1, confirming that these proteins are key targets for miR-155-mediated immune evasion during viral infections.

Conclusions

The findings establish a novel miR-155-dependent pathway whereby ALV-J sidesteps host immune defenses, ultimately promoting viral replication and persistence. This mechanism illustrates the complex dynamics of host-virus interactions and opens avenues for future research into potential therapeutic targets that could disrupt these viral evasion strategies.

Data Availability

All data supporting this research are provided in the manuscript and supplementary files.

Funding

This study received financial support from several sources, including the Natural Science Foundation of China and the Key Research and Development Program of Shandong Province.

Keywords

  • Avian leukosis virus subgroup J
  • miR-155
  • Innate immunity
  • TRAF3
  • STAT1
  • Viral replication

Diseases & Conditions

Share This Article
Facebook LinkedIn Email Copy Link

HOT NEWS

Understanding the Key Difference Between PCOD vs PCOS: What Every Woman Should Know

Understanding the Key Difference Between PCOD vs PCOS: What Every Woman Should Know

February 6, 2026
Shilajit Benefits

Shilajit Benefits: Ancient Himalayan Secret for Energy, Brain Health, and Longevity

Shilajit is a gummy, resinous material that drips from crevices in rocks located on high mountains, primarily the Himalayas. Notably, it has been a natural remedy highly praised…

February 5, 2026

Weight-Loss Drugs Require Lifelong Use, New Study Indicates

Experts say weight-loss medications like Wegovy require lifelong use to maintain results, as stopping treatment…

January 26, 2026

Affordable Grain-Based Dishes for a Healthier Diet

These affordable grain-based recipes make it easy to enjoy healthy, plant-forward meals while saving money…

January 26, 2026

YOU MAY ALSO LIKE

Structure Therapeutics Faces Challenges with Weight-Loss Treatments

Structure Therapeutics is preparing to launch its weight-loss pill while confronting growing risks from unregulated compounded copycat drugs.

January 16, 2026

FDA to Decide on Biohaven’s Ataxia Treatment in November

As the FDA weighs Biohaven’s SCA drug approval, patients and investors await a pivotal decision that could reshape rare disease…

October 27, 2025

Understanding Superspreading and Pathogen Virulence Evolution

Superspreading alters how pathogens evolve, influencing virulence, transmission, and long-term epidemic behavior across diverse host populations.

October 30, 2025

AstraZeneca and Daiichi Sankyo Achieve Milestone in Cancer Study

AstraZeneca and Daiichi Sankyo’s Datroway achieved major success in a late-stage trial, offering new hope for patients with triple-negative breast…

October 8, 2025

Medical Herald is your trusted source for medical news, scientific research, health policy updates, and expert insights from around the world. 

Category

  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
  • Privacy Policy
  • About Us
  • Contact

Follow US: 

  • Grow Big Agency Sites:
  • London Business Journal
Copyright © 2026, Medical Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?